A detailed history of Northern Trust Corp transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 575,880 shares of EWTX stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
575,880
Previous 508,691 13.21%
Holding current value
$13.9 Million
Previous $9.16 Million 67.78%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.88 - $29.5 $1.07 Million - $1.98 Million
67,189 Added 13.21%
575,880 $15.4 Million
Q2 2024

Aug 14, 2024

BUY
$15.08 - $21.23 $138,298 - $194,700
9,171 Added 1.84%
508,691 $9.16 Million
Q1 2024

May 14, 2024

BUY
$9.25 - $19.97 $1.26 Million - $2.72 Million
136,277 Added 37.52%
499,520 $9.11 Million
Q4 2023

Feb 13, 2024

BUY
$5.51 - $12.1 $100,981 - $221,756
18,327 Added 5.31%
363,243 $3.97 Million
Q3 2023

Nov 13, 2023

BUY
$5.73 - $7.69 $31,280 - $41,979
5,459 Added 1.61%
344,916 $1.98 Million
Q2 2023

Aug 11, 2023

BUY
$5.71 - $10.29 $190,559 - $343,408
33,373 Added 10.9%
339,457 $2.63 Million
Q1 2023

May 15, 2023

SELL
$6.66 - $11.33 $71,581 - $121,774
-10,748 Reduced 3.39%
306,084 $2.04 Million
Q4 2022

Feb 13, 2023

BUY
$7.58 - $11.08 $590,724 - $863,486
77,932 Added 32.62%
316,832 $2.83 Million
Q3 2022

Nov 14, 2022

BUY
$8.08 - $13.58 $174,794 - $293,776
21,633 Added 9.96%
238,900 $2.35 Million
Q2 2022

Aug 12, 2022

SELL
$5.67 - $9.87 $434,803 - $756,880
-76,685 Reduced 26.09%
217,267 $1.73 Million
Q1 2022

May 13, 2022

SELL
$9.1 - $18.97 $74,965 - $156,274
-8,238 Reduced 2.73%
293,952 $2.85 Million
Q4 2021

Feb 08, 2022

BUY
$14.41 - $22.41 $2.69 Million - $4.18 Million
186,617 Added 161.47%
302,190 $4.62 Million
Q3 2021

Nov 15, 2021

SELL
$14.11 - $24.1 $157,411 - $268,859
-11,156 Reduced 8.8%
115,573 $1.92 Million
Q2 2021

Aug 13, 2021

BUY
$21.33 - $30.25 $2.7 Million - $3.83 Million
126,729 New
126,729 $2.7 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.53B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.